Table 3. Patient biochemical and CMR characteristics per aortic stenosis severity group.
| Biochemical and CMR data | Mild / Moderate | Severe | P-Value |
|---|---|---|---|
| Lp(a), mg/L | 420 ± 344 | 404 ± 390 | 0.64 |
| Creatinine, μmol/L | 93 ± 30 | 102 ± 36 | 0.20 |
| CMR aortic valve area, cm2 | 1.2 ± 0.3 | 0.7 ± 0.1 | <0.00001 |
| LVEF, % | 62 ± 14 | 57 ± 17 | 0.11 |
| LV Mass, g | 166 ± 47 | 168 ± 57 | 0.87 |
| CMR Myocardial Tissue Characterisation | |||
| No Myocardial Fibrosis, n (%) | 13 (37.1) | 23 (30.7) | 0.82 |
| Midwall Fibrosis, n (%) | 11 (31.4) | 27 (36.0) | |
| Infarction Pattern Fibrosis, n(%) | 11 (31.4) | 25 (33.3) | |
| Lp(a) by CMR Fibrosis Group | |||
| No Myocardial Fibrosis, mg/L | 377 ± 416 | 418 ± 406 | 0.93 |
| Midwall Fibrosis, mg/L | 421 ± 333 | 360 ± 389 | 0.46 |
| Infarction Pattern fibrosis, mg/L | 469 ± 278 | 438 ± 389 | 0.74 |